Fortrea

Ophthalmology Perspectives

Health EN ↓ Odcinki: 3

Here we explore the evolving landscape of ophthalmology clinical trials and look ahead to the most promising trends shaping the future of ophthalmology trials.

Koniecznie odwiedź stronę podcastu i wesprzyj twórcę: async.com

Autor

Fortrea

Kategoria

Health

Strona podcastu

async.com

Ostatni odcinek

20 mar 2026

Gdzie słuchać?

Podcasty w aplikacji Replaio Radio Już wkrótce

Podcasty trafią do aplikacji już wkrótce. Zainstaluj teraz i jako pierwszy zobacz nowe podejście do podcastów

Zainstaluj za darmo Android 5 mln+ pobrań · ocena 4,8 iOS niedługo

Odcinki

Ophthalmology Perspectives | Ep 3 | Gene Therapy, Patient-Centric Operations, and Risk-Benefit Challenges in Phase 1 Ophthalmology Trials 20.03.2026 30:45

Today we explore the unique challenges and opportunities in Phase 1 ophthalmology clinical trials, focusing on gene therapy and inherited retinal diseases.

Ophthalmology Perspectives | Ep 2 | Ophthalmology Trials at the Leeds CPU 20.03.2026 11:29

In today’s episode, we delve into the fascinating world of Phase 1 clinical research at Fortrea’s Leeds Clinical Pharmacology Unit in the UK. We explore the operational challenges and innovative solutions behind a recent, complex ophthalmology clinical trial.

Ophthalmology Perspectives | Ep 1 | Patient Recruitment in Ophthalmology Trials 20.03.2026 14:33

In this conversation, we to dive into the evolving landscape of patient recruitment in ophthalmology and explore how Belite Bio and Fortrea are collaborating to overcome protocol complexities, and discuss the unique opportunities Asia PAC represents for ocular development. We'll also look ahead to the most promising trends shaping the future of ophthalmology trials.